March 17, 2023

 

VIA EDGAR

 

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tyler Howes

 

 

RE:	Vistagen Therapeutics, Inc.
	Registration Statement on Form S-3
	(File No. 333-270232)

 

Dear Mr. Howes,

 

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, Vistagen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 4:00 p.m. Eastern Standard Time on Tuesday, March 21, 2023, or as soon as practicable thereafter.

 

Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Mr. Daniel Rumsey at (619) 272-7062, to confirm the exact time at which the Registration Statement was declared effective.

 

 

	Very truly yours,
	VISTAGEN THERAPEUTICS, INC.
	/s/ Shawn K. Singh
	Shawn K. Singh
	Chief Executive Officer

 

 

 

cc:	Daniel W. Rumsey

Disclosure Law Group, a Professional Corporation